Risk factors for recurrence of CMV infection following nonmyeloablative transplantation
| Variable . | Reactivation < 100 d . | Reactivation > 100 d . | Overall reaction . | |||
|---|---|---|---|---|---|---|
| OR (P) . | 95% CI . | OR (P) . | 95% CI . | OR (P) . | 95% CI . | |
| Unrelated donor | ||||||
| Univariate | 3.3 (0.005)3-150 | 1.4-7.8 | 3.5 (0.01)3-150 | 1.3-9.6 | 3.5 (0.002)3-150 | 1.5-7.9 |
| Multivariate | Not done | 2.4 (0.2) | 0.57-10.2 | 7.5 (0.001)3-150 | 2.1-26.9 | |
| CD4+ T-cell count at 3 mo | ||||||
| Univariate | 0.9 (0.2) | 0.9-1.0 | 0.98 (0.04)3-150 | 0.96-0.99 | 0.99 (0.08)3-151 | 0.97-1.0 |
| Multivariate | Not done | 0.98 (0.08)3-151 | 0.96-1.0 | 0.98 (0.06)3-151 | 0.98-1.0 | |
| Duration of previous episode(s) | ||||||
| Univariate | 0.9 (0.1) | 0.9-1.0 | 1.03 (0.01)3-150 | 1.0-1.06 | 0.99 (0.6) | 0.95-1.02 |
| Multivariate | Not done | 1.03 (0.2) | 0.97-1.09 | Not entered | ||
| Variable . | Reactivation < 100 d . | Reactivation > 100 d . | Overall reaction . | |||
|---|---|---|---|---|---|---|
| OR (P) . | 95% CI . | OR (P) . | 95% CI . | OR (P) . | 95% CI . | |
| Unrelated donor | ||||||
| Univariate | 3.3 (0.005)3-150 | 1.4-7.8 | 3.5 (0.01)3-150 | 1.3-9.6 | 3.5 (0.002)3-150 | 1.5-7.9 |
| Multivariate | Not done | 2.4 (0.2) | 0.57-10.2 | 7.5 (0.001)3-150 | 2.1-26.9 | |
| CD4+ T-cell count at 3 mo | ||||||
| Univariate | 0.9 (0.2) | 0.9-1.0 | 0.98 (0.04)3-150 | 0.96-0.99 | 0.99 (0.08)3-151 | 0.97-1.0 |
| Multivariate | Not done | 0.98 (0.08)3-151 | 0.96-1.0 | 0.98 (0.06)3-151 | 0.98-1.0 | |
| Duration of previous episode(s) | ||||||
| Univariate | 0.9 (0.1) | 0.9-1.0 | 1.03 (0.01)3-150 | 1.0-1.06 | 0.99 (0.6) | 0.95-1.02 |
| Multivariate | Not done | 1.03 (0.2) | 0.97-1.09 | Not entered | ||